What's New

Last Posted: Aug 22, 2023

• Identifying patients at risk for hereditary myeloid malignancy syndromes incorporating a novel, self-administered questionnaire to an initial screening platform.
  Mohammad Faizan Zahid et al. Eur J Haematol 2023
• ASSESSING PATIENT ATTITUDES TOWARD GENETIC TESTING FOR HEREDITARY HEMATOLOGIC MALIGNANCY.
  Johnson Addison Q et al. European journal of haematology 2022
• Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.
  McReynolds Lisa J et al. Blood 2022
• A Deep Learning Model for the Automatic Recognition of Aplastic Anemia, Myelodysplastic Syndromes, and Acute Myeloid Leukemia Based on Bone Marrow Smear.
  Wang Meifang et al. Frontiers in oncology 2022 12844978
• The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.
  Shah Yash B et al. Blood advances 2021 5(16) 3216-3226
• The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia.
  Zheng Gang et al. American journal of hematology 2019 Jul
• Clinical applicability of proposed algorithm for identifying individuals at risk for hereditary hematologic malignancies.
  Clifford Maggie et al. Leukemia & lymphoma 2019 Jul 1-8
• Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic age.
  Maciejewski Jaroslaw P et al. Hematology. American Society of Hematology. Education Program 2017 2017(1) 66-72
• Local Coverage Determination (LCD): Flow Cytometry (L33661)
  The U.S. Centers for Medicare & Medicaid Services
• Old and new tools in the clinical diagnosis of inherited bone marrow failure syndromes.
  West Allison H et al. Hematology. American Society of Hematology. Education Program 2017 2017(1) 79-87

More